EGFR-CAR-T

N/A

Report date: 2025/01/26 19:06:06

Base Information

Drug NameEGFR-CAR-T

Drug Alias Nameanti-EGFR CAR T-cell therapy (China Immunotech)EGFR-CAR-T

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionEpidermal growth factor receptor erbB1 modulators

TargetsEpidermal growth factor receptor erbB1

Therapy Area/IndicationsLung Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesChina Immunotech Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesChina Immunotech Co Ltd

Inactive CompaniesN/A

Active IndicationsLung Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A